Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer

by Imai H, Saijo K, Komine K, Kawamura Y, Hiraide S, Umegaki S, Okada Y, Ouchi K, Sato Y, Takahashi M, Takahashi S, Shirota H, Takahashi M, Ishioka C
Published 2018-09-01

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients

by Olivier, M, Langerød, A, Carrieri, P, Bergh, J, Klaar, S, Eyfjord, J, Theillet, C, Rodriguez, C, Lidereau, R, Bièche, I, Varley, J, Bignon, Y, Uhrhammer, N, Winqvist, R, Jukkola-Vuorinen, A, Niederacher, D, Kato, S, Ishioka, C, Hainaut, P, Børresen-Dale, A-L
Published 2005